ADORA2A and decubitus ulcer: Clinically, PDRN has been employed in the treatment of chronic wounds, pressure ulcers, and various skin lesions due to its ability to promote tissue repair, angiogenesis, and anti-inflammatory responses via activation of A2AR pathways.